About IRIDEX Corp. 
IRIDEX Corp.
Pharmaceuticals & Biotechnology
IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.
Company Coordinates 
Company Details
1212 Terra Bella Ave , MOUNTAIN VIEW CA : 94043-1824
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 5 Schemes (7.0%)
Foreign Institutions
Held by 6 Foreign Institutions (0.5%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Robert Gunst
Independent Chairman of the Board
Mr. David Bruce
President, Chief Executive Officer, Director
Ms. Doris Engibous
Independent Director
Dr. Robert Grove
Independent Director
Mr. Kenneth Ludlum
Independent Director
Mr. Scott Shuda
Independent Director
Revenue and Profits:
Net Sales:
14 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
Pharmaceuticals & Biotechnology
USD 23 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.32
-89.90%
3.87






